Anti-RBL1 monoclonal antibody

Pre-made anti-RBL1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RBL1/RBL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1473-Ab-1/ GM-Tg-hg-IP1473-Ab-2Anti-Human RBL1 monoclonal antibodyHuman
GM-Tg-rg-IP1473-Ab-1/ GM-Tg-rg-IP1473-Ab-2Anti-Rat RBL1 monoclonal antibodyRat
GM-Tg-mg-IP1473-Ab-1/ GM-Tg-mg-IP1473-Ab-2Anti-Mouse RBL1 monoclonal antibodyMouse
GM-Tg-cynog-IP1473-Ab-1/ GM-Tg-cynog-IP1473-Ab-2Anti-Cynomolgus/ Rhesus macaque RBL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1473-Ab-1/ GM-Tg-felg-IP1473-Ab-2Anti-Feline RBL1 monoclonal antibodyFeline
GM-Tg-cang-IP1473-Ab-1/ GM-Tg-cang-IP1473-Ab-2Anti-Canine RBL1 monoclonal antibodyCanine
GM-Tg-bovg-IP1473-Ab-1/ GM-Tg-bovg-IP1473-Ab-2Anti-Bovine RBL1 monoclonal antibodyBovine
GM-Tg-equg-IP1473-Ab-1/ GM-Tg-equg-IP1473-Ab-2Anti-Equine RBL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1473-Ab-1/ GM-Tg-hg-IP1473-Ab-2; GM-Tg-rg-IP1473-Ab-1/ GM-Tg-rg-IP1473-Ab-2;
GM-Tg-mg-IP1473-Ab-1/ GM-Tg-mg-IP1473-Ab-2; GM-Tg-cynog-IP1473-Ab-1/ GM-Tg-cynog-IP1473-Ab-2;
GM-Tg-felg-IP1473-Ab-1/ GM-Tg-felg-IP1473-Ab-2; GM-Tg-cang-IP1473-Ab-1/ GM-Tg-cang-IP1473-Ab-2;
GM-Tg-bovg-IP1473-Ab-1/ GM-Tg-bovg-IP1473-Ab-2; GM-Tg-equg-IP1473-Ab-1/ GM-Tg-equg-IP1473-Ab-2
Products NameAnti-RBL1 monoclonal antibody
Formatmab
Target NameRBL1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RBL1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1473-Ag-1Recombinant multi-species RBL1/ CP107/ PRB1 protein


    Target information

    Target IDGM-IP1473
    Target NameRBL1
    Gene ID5933,19650,680111,701650,477221,101095164,524870,100069786
    Gene Symbol and SynonymsCP107,p107,PRB1,RBL1
    Uniprot AccessionP28749,D3ZS28
    Uniprot Entry NameRBL1_HUMAN,RBL1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000080839
    Target ClassificationTumor-associated antigen (TAA)

    The target: RBL1, gene name: RBL1, also named as CP107, PRB1, p107. The protein encoded by this gene is similar in sequence and possibly function to the product of the retinoblastoma 1 (RB1) gene. The RB1 gene product is a tumor suppressor protein that appears to be involved in cell cycle regulation, as it is phosphorylated in the S to M phase transition and is dephosphorylated in the G1 phase of the cell cycle. Both the RB1 protein and the product of this gene can form a complex with adenovirus E1A protein and SV40 large T-antigen, with the SV40 large T-antigen binding only to the unphosphorylated form of each protein. In addition, both proteins can inhibit the transcription of cell cycle genes containing E2F binding sites in their promoters. Due to the sequence and biochemical similarities with the RB1 protein, it is thought that the protein encoded by this gene may also be a tumor suppressor. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.